Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on the Efficacy, Safety, and Tolerability of GAlcanezumab in Real Life Migraine Patients in ITaly (GARLIT)

NCT04803513 is registered in ClinicalTrials.gov with Campus Bio-Medico University as lead sponsor.

NCT NCT04803513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04803513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on the Efficacy, Safety, and Tolerability of GAlcanezumab in Real Life Migraine Patients in ITaly (GARLIT)
Lead sponsor
Campus Bio-Medico University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
August 31, 2022
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine